| Structure |
Chemical Name |
CAS |
MF |
 |
Cisatracurium besylate impurity 21 |
|
|
|
|
Dacomitinib Impurity |
|
|
 |
6-O-DESMETHYL DONEPEZIL |
120013-56-1 |
C23H27NO3 |
 |
2-(2-METHYL-4-NITRO-IMIDAZOL-1-YL)-ETHANOL |
705-19-1 |
C6H9N3O3 |
 |
2,6-DIMETHYL-4-(3-NITRO-PHENYL)-PYRIDINE-3,5-DICARBOXYLIC ACID DIMETHYL ESTER |
76258-20-3 |
C17H16N2O6 |
 |
3-(2-TRIFLUOROMETHYL-PHENYL)-PROPAN-1-OL |
191155-81-4 |
C10H11F3O |
|
|
N,N-bis((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)pyridine-3-sulfonamide |
2514957-29-8 |
C27H22F2N4O2S |
 |
2,4(1H,3H)-Pyrimidinedione, 1-β-L-ribofuranosyl-, 4-oxime (9CI) |
402725-23-9 |
C9H13N3O6 |
 |
1H-Indole-2-sulfonic acid, 6-hydroxy-1-methyl- |
2271443-87-7 |
C9H9NO4S |
 |
methyl 4-hydroxy-2-oxopyrrolidine-1-acetate |
85614-52-4 |
C7H11NO4 |
|
|
Sitagliptin EP Impurity 5 |
|
|
|
|
Simvastatin Impurity 6 |
|
|
|
|
Anastrozole Impurity 14 |
|
|
|
|
Pemetrexed Impurity 42 |
|
|
 |
2-(6-Aminopurin-9-yl)ethanol |
707-99-3 |
C7H9N5O |
![9-Azabicyclo[3.3.1]Nonane-9-Acetic Acid, 3-(Ethoxycarbonyl)-7-Oxo-, Ethyl Ester](/CAS/GIF/115956-03-1.gif) |
9-Azabicyclo[3.3.1]Nonane-9-Acetic Acid, 3-(Ethoxycarbonyl)-7-Oxo-, Ethyl Ester |
115956-03-1 |
C15H23NO5 |
|
|
Cefathiamidine Impurity F |
|
|
 |
1-(Bromophenylmethyl)-4-chlorobenzene |
948-54-9 |
C13H10BrCl |
|
|
Flomoxef oxidation impurities |
|
|
|
|
Toltrazuril Impurity 1 |
|
|
|
|
((2R,3R,5S)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-4,4-difluoro-3-hydroxytetrahydrofuran-2-yl)methyl benzoate |
|
|
|
|
Aprepitant Impurity 53 |
|
|
|
|
Cetrorelix Impurity 21 |
|
|
|
|
Brivaracetam Impurity 43 |
|
|
|
|
NA |
|
|
|
|
Peramivir Intermediate Impurity 37 |
|
|
|
|
Peramivir Diastereomer Impurity 1 |
|
|
|
|
NA |
|
|
|
|
Canagliflozin Impurities 999 |
|
|
|
|
1,4,8,11-tetraazacyclotetradecane sodium chelation |
|
|
|
|
NA |
|
|
 |
4-Methoxy-2,3,5-trimethylpyride-N-oxide |
86604-80-0 |
C9H13NO2 |
 |
1-BOC-4-(5-NITRO-2-PYRIDYL)PIPERAZINE |
193902-78-2 |
C14H20N4O4 |
|
|
(1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-phenylacetate |
|
|
|
|
Relugolix Impurity 25 |
|
|
|
|
Lumateperone Impurity 5 |
|
|
|
|
Sugammadex Sodium Impurity ORG139131-1 |
|
|
|
|
2-[4-(Azidomethyl)phenyl]benzoic acid |
|
|
![2-[(2-AZIDOETHOXY)METHYL]-4-(2-CHLOROPHENYL)-3-ETHOXYCARBONYL-5-METHOXYCARBONYL)-6-METHYL-1,4-DIHYDROPYRIDINE](/CAS/GIF/88150-46-3.gif) |
2-[(2-AZIDOETHOXY)METHYL]-4-(2-CHLOROPHENYL)-3-ETHOXYCARBONYL-5-METHOXYCARBONYL)-6-METHYL-1,4-DIHYDROPYRIDINE |
88150-46-3 |
C20H23ClN4O5 |
|
|
((6aR,9R,10aR)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl)methanol acetic acid salt |
|
|
|
|
Brivaracetam Impurity 56 |
|
|
|
|
Oxytocin Impurity 3 |
|
|
|
|
Rosuvastatin Impurity 158 |
|
|
|
|
Rosuvastatin Impurity 139 |
|
|
|
|
Rosuvastatin Impurity 124 |
|
|
 |
Ethyl 5,6-dichloro-3,4-dihydro-2(1H)-iminoquinazoline-3-acetate hydrobromide |
70381-75-8 |
C12H14BrCl2N3O2 |
 |
4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro- |
79617-95-1 |
C17H17Cl2N |
|
|
Avatrombopag Impurity 77 |
|
|
|
|
methyl 5-((4-(3-carbamoyl-1-(4-methoxyphenyl)-7-oxo-1,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)phenyl)amino)pentanoate |
|
|
|
|
N-(4-((3-chloro-4-fluorophenyl)amino)-7-fluoroquinazolin-6-yl)-4-(dimethylamino)butanamide |
|
|
|
|
Ertapenem Impurity A(USP) |
|
|
![D-Glutamic acid, 4-(cyanomethyl)-N-[(1,1-dimethylethoxy)carbonyl]-, 1,5-dimethyl ester, (4S)-rel-](/CAS/20210305/GIF/2740644-40-8.gif) |
D-Glutamic acid, 4-(cyanomethyl)-N-[(1,1-dimethylethoxy)carbonyl]-, 1,5-dimethyl ester, (4S)-rel- |
2740644-40-8 |
C14H22N2O6 |
|
|
2-hydroxy-3-oxobutyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate |
|
|
 |
INDEX NAME NOT YET ASSIGNED |
2731089-65-7 |
C27H34N2O6 |
 |
(9S)-9-Amino-9-deoxoerythromycin |
26116-56-3 |
C37H70N2O12 |
 |
NSC525120 |
10221-08-6 |
C8H7Cl3 |
 |
3-(2-cyanoethyl-(2-hydroxyethyl)amino)propanenitrile |
6305-56-2 |
C8H13N3O |
![TRANS-4-[[(2-AMINOPHENYL)METHYL]AMINO]-CYCLOHEXANOL](/CAS/20150408/GIF/46727-91-7.gif) |
TRANS-4-[[(2-AMINOPHENYL)METHYL]AMINO]-CYCLOHEXANOL |
46727-91-7 |
C13H20N2O |
|
|
Citalopram Related Compound F |
|
|
![(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1-[(1R,4S)-1,4,5-trimethylhexyl]-1H-Indene](/CAS/20210111/GIF/2229745-37-1.gif) |
(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1-[(1R,4S)-1,4,5-trimethylhexyl]-1H-Indene |
2229745-37-1 |
C40H74O2Si2 |
 |
Lexithromycin |
53066-26-5 |
C38H70N2O13 |
 |
methylprednisolone 17-hemisuccinate |
77074-42-1 |
C26H34O8 |
|
|
8-hydroxymethylriboflavin |
52134-62-0 |
C17H20N4O7 |
 |
RS 42358-197 |
135729-55-4 |
C19H23ClN2O |
 |
acetylthiamine |
3419-28-1 |
|
 |
deacetylcephalosporin C |
1476-46-6 |
C14H19N3O7S |
 |
ETHYLVANILLINBETA-D-GLUCOPYRANOSIDE |
122397-96-0 |
C15H20O8 |
 |
4-(2-Cyanophenyl)benzyl alcohol |
154709-19-0 |
C14H11NO |
![1-Propanol, 3-[[2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-3-methyl-4-pyridinyl]oxy]-](/CAS/GIF/117976-94-0.gif) |
1-Propanol, 3-[[2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-3-methyl-4-pyridinyl]oxy]- |
117976-94-0 |
C17H19N3O3S |
 |
2',3'-O-isopropylidene cytidine |
362-42-5 |
C12H17N3O5 |
 |
4,4''-Dimethoxyazoxybenzene |
501-58-6 |
C14H14N2O2 |
 |
3,5-Dibenzyloxy terbutalline |
28924-25-6 |
C26H31NO3 |
 |
1H-BENZIMIDAZOLE,2-CHLORO-1-(2-ETHOXYETHYL) |
87233-54-3 |
C11H13ClN2O |
 |
2,2-Dimethyl-4-isopropyl-1,3-benzodioxole (Propofol Impurity L) |
201166-22-5 |
C12H16O2 |
 |
24Dichloro-5methoxyacetanilide |
65182-98-1 |
C9H9Cl2NO2 |
 |
4,4,4-trifluoro-1-(2-methylphenyl)butane-1,3-dione |
163266-02-2 |
C11H9F3O2 |
 |
5-chloro-N-(4-nitrophenyl)pentanamide |
1039914-85-6 |
C11H13ClN2O3 |
|
|
2-(2-ethoxy-3-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one |
|
|
|
|
Bumetanide Photodegradable Impurity 15 |
|
|
|
|
Bisoprolol Impurity 48 |
|
|
![Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-amino-2-hydroxy-, methyl ester, (1S,2S,3R,4R)-, mono(trifluoroacetate) (salt) (9CI)](/CAS/20211123/GIF/357448-34-1.gif) |
Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-amino-2-hydroxy-, methyl ester, (1S,2S,3R,4R)-, mono(trifluoroacetate) (salt) (9CI) |
357448-34-1 |
C17H29F3N2O6 |
|
|
Dobutamine Impurity 16 |
|
|
|
|
Faropenem Impurity AB |
|
|
|
|
Nirmatrelvir Impurity 9 |
|
|
 |
4-nitro-1H-Imidazole-2-carboxaldehyde |
33543-81-6 |
C4H3N3O3 |
 |
1-CHLOROMETHYL-2,3,4-TRIMETHOXYBENZENE |
1133-49-9 |
C10H13ClO3 |
|
|
Bumetanide Impurity 19 |
|
|
|
|
Rocuronium Bromide Impurity 26 、27 |
|
|
|
|
Roxadustat Impurity 20 |
|
|
|
|
Ruxolitinib Impurity |
|
|
|
|
Sitagliptin Impurity 82 |
|
|
|
|
(1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran- 2-yl)ethyl)-3,7-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl 2,2-dimethylbutanoate |
|
|
|
|
Perospirone Impurity 21 |
|
|
|
|
Perospirone Impurity 11 |
|
|
|
|
Dolutegravir Impurity 21 |
|
|
|
|
NA |
|
|
|
|
Fondaparinux sodium impurity 7 |
|
|
|
|
Fondaparinux sodium impurity 3 |
|
|
|
|
Oxacillin sodium Impurity B |
|
|
|
|
Revefenacin Impurity 21 |
|
|